Banco Santander’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.7M | Sell |
266,424
-9,611
| -3% | -$1.27M | 0.21% | 76 |
|
|
2026
Q1 | $38.5M | Buy |
276,035
+14,191
| +5% | +$1.99M | 0.31% | 48 |
|
|
2025
Q4 | $32.1M | Buy |
261,844
+128,848
| +97% | +$15.7M | 0.24% | 71 |
|
|
2025
Q3 | $14.8M | Sell |
132,996
-201
| -0.2% | -$22.8K | 0.13% | 116 |
|
|
2025
Q2 | $14.8M | Sell |
133,197
-26,647
| -17% | -$2.84M | 0.14% | 110 |
|
|
2025
Q1 | $17.9M | Buy |
159,844
+18,269
| +13% | +$1.89M | 0.2% | 87 |
|
|
2024
Q4 | $13.1M | Sell |
141,575
-131,985
| -48% | -$11.9M | 0.16% | 104 |
|
|
2024
Q3 | $22.9M | Sell |
273,560
-66,268
| -20% | -$5.06M | 0.27% | 66 |
|
|
2024
Q2 | $23.3M | Buy |
339,828
+123,756
| +57% | +$8.26M | 0.29% | 56 |
|
|
2024
Q1 | $15.8M | Buy |
+216,072
| New | +$16.6M | 0.19% | 81 |
|
|
2023
Q2 | – | Sell |
-2,463
| Closed | -$204K | – | 414 |
|
|
2023
Q1 | $204K | Buy |
+2,463
| New | +$204K | ﹤0.01% | 346 |
|
|
2022
Q2 | – | Sell |
-21,213
| Closed | -$1.26M | – | 399 |
|
|
2022
Q1 | $1.26M | Buy |
21,213
+5,665
| +36% | +$362K | 0.01% | 268 |
|
|
2021
Q4 | $1.13M | Buy |
15,548
+1,228
| +9% | +$84.6K | 0.01% | 302 |
|
|
2021
Q3 | $1M | Sell |
14,320
-1,348
| -9% | -$94.7K | 0.01% | 297 |
|
|
2021
Q2 | $1.08M | Buy |
+15,668
| New | +$1.05M | 0.01% | 259 |
|
|
2020
Q4 | – | Sell |
-9,298
| Closed | -$588K | – | 381 |
|
|
2020
Q3 | $588K | Sell |
9,298
-6,527
| -41% | -$453K | 0.01% | 280 |
|
|
2020
Q2 | $1.22M | Sell |
15,825
-1,228,415
| -99% | -$94.1M | 0.02% | 196 |
|
|
2020
Q1 | $93M | Buy |
1,244,240
+1,228,709
| +7,911% | +$84.9M | 1.06% | 13 |
|
|
2019
Q4 | $1.01M | Sell |
15,531
-1,706
| -10% | -$111K | 0.01% | 251 |
|
|
2019
Q3 | $1.09M | Sell |
17,237
-914,982
| -98% | -$59.8M | 0.01% | 235 |
|
|
2019
Q2 | $63M | Buy |
932,219
+913,442
| +4,865% | +$60.1M | 0.64% | 14 |
|
|
2019
Q1 | $1.22M | Buy |
18,777
+8,872
| +90% | +$590K | 0.01% | 214 |
|
|
2018
Q4 | $619K | Buy |
9,905
+1,585
| +19% | +$111K | 0.01% | 287 |
|
|
2018
Q3 | $643K | Sell |
8,320
-7,213
| -46% | -$545K | 0.01% | 295 |
|
|
2018
Q2 | $1.1M | Sell |
15,533
-1,531
| -9% | -$108K | 0.01% | 223 |
|
|
2018
Q1 | $1.29M | Sell |
17,064
-15,904
| -48% | -$1.26M | 0.02% | 225 |
|
|
2017
Q4 | $2.36M | Sell |
32,968
-2,838
| -8% | -$216K | 0.03% | 118 |
|
|
2017
Q3 | $2.9M | Sell |
35,806
-416
| -1% | -$31.8K | 0.05% | 111 |
|
|
2017
Q2 | $2.57M | Sell |
36,222
-2,930
| -7% | -$195K | 0.05% | 86 |
|
|
2017
Q1 | $2.66M | Buy |
39,152
+2,133
| +6% | +$150K | 0.07% | 62 |
|
|
2016
Q4 | $2.51M | Buy |
+37,019
| New | +$2.75M | 0.07% | 70 |
|
Other funds holding GILD
Banco Santander's GILD Position: Q2 2026 in Review
Banco Santander reduced its Gilead Sciences (GILD) stake by 3.5% in Q2 2026, selling an estimated $1.27M and leaving 266,424 shares worth $33.7M. The position accounts for 0.21% of the portfolio, ranked #76.
Banco Santander first reported a position in GILD in Q4 2016 and has held it in 31 quarters since. The position peaked at $93M in Q1 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Banco Santander held 266,424 shares of Gilead Sciences worth $33.7M as of Q2 2026.
- Banco Santander sold 9,611 Gilead Sciences shares in Q2 2026, an estimated $1.27M.
- Gilead Sciences made up 0.21% of Banco Santander's portfolio in Q2 2026, its #76 holding.
- Banco Santander first reported a position in Gilead Sciences in Q4 2016 and has held it in 31 quarters since.
- Banco Santander's Gilead Sciences position peaked at $93M in Q1 2020.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.